Naseem Cassim to Mass Screening
This is a "connection" page, showing publications Naseem Cassim has written about Mass Screening.
Connection Strength
0,952
-
Prostate cancer age-standardised incidence increase between 2006 and 2016 in Gauteng Province, South Africa: A laboratory data-based analysis. S Afr Med J. 2020 Dec 14; 111(1):26-32.
Score: 0,629
-
Establishing a cost-per-result of laboratory-based, reflex Cryptococcal antigenaemia screening (CrAg) in HIV+ patients with CD4 counts less than 100 cells/µl using a Lateral Flow Assay (LFA) at a typical busy CD4 laboratory in South Africa. PLoS One. 2017; 12(2):e0171675.
Score: 0,120
-
Estimating implementation and operational costs of an integrated tiered CD4 service including laboratory and point of care testing in a remote health district in South Africa. PLoS One. 2014; 9(12):e115420.
Score: 0,104
-
Mining laboratory data to describe prostate specific antigen testing and prostate cancer in Johannesburg, South Africa. Pan Afr Med J. 2020; 35:61.
Score: 0,037
-
Cryptococcal antigen positivity combined with the percentage of HIV-seropositive samples with CD4 counts <100 cells/µl identifies districts in South Africa with advanced burden of disease. PLoS One. 2018; 13(6):e0198993.
Score: 0,033
-
Screening HIV-Infected Patients with Low CD4 Counts for Cryptococcal Antigenemia prior to Initiation of Antiretroviral Therapy: Cost Effectiveness of Alternative Screening Strategies in South Africa. PLoS One. 2016; 11(7):e0158986.
Score: 0,029